Published 30-day Notice

Federal Register / Vol. 88, No. 108 / Tuesday, June 6, 2023 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

National Institutes of Health

National Institutes of Health

National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting

National Cancer Institute; Notice of
Meeting

Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.

ddrumheller on DSK120RN23PROD with NOTICES1

Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; HIV-Comorbidities
within Areas Relevant to NIDDK.
Date: July 14, 2023.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute of Diabetes and Digestive
and Kidney Diseases, Democracy II, 6707
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Maria E. Davila-Bloom,
Ph.D., Scientific Review Officer, Scientific
Review Branch, Division of Extramural
Activities, National Institutes of Health,
National Institute of Diabetes and Digestive
and Kidney Diseases, Democracy II, Suite
7000A, 6707 Democracy Boulevard, (301)
594–7637, davila-bloomm@
extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: May 31, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–11971 Filed 6–5–23; 8:45 am]
BILLING CODE 4140–01–P

VerDate Sep<11>2014

19:24 Jun 05, 2023

Jkt 259001

Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Cancer Institute
Clinical Trials and Translational
Research Advisory Committee.
This will be a hybrid meeting held inperson and virtually and will be open to
the public as indicated below.
Individuals who plan to attend inperson or view the virtual meeting and
need special assistance or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The meeting
can be accessed from the NIH Videocast
at the following link: https://
videocast.nih.gov/.
Name of Committee: National Cancer
Institute Clinical Trials and Translational
Research Advisory Committee.
Date: July 19, 2023.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: Strategic Discussion of NCI’s
Clinical and Translational Research
Programs.
Place: National Cancer Institute Shady
Grove, East Wing, Conference Room TE406/
408/410, 9609 Medical Center Drive,
Rockville, MD 20850, (Hybrid).
Contact Person: Sheila A. Prindiville, M.D.,
M.P.H., Director, Coordinating Center for
Clinical Trials, National Cancer Institute,
National Institutes of Health, 9609 Medical
Center Drive, Room 6W136, Rockville, MD
20850, 240–276–6173, prindivs@
mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NCI Shady Grove
has instituted stringent procedures for
entrance into the NCI Shady Grove building.
Visitors will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: http://
deainfo.nci.nih.gov/advisory/ctac/ctac.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,

PO 00000

Frm 00073

Fmt 4703

Sfmt 4703

37077

Cancer Control, National Institutes of Health,
HHS)
Dated: May 31, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–11968 Filed 6–5–23; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Office of Minority
Health Research Coordination
(OMHRC) Research Training and
Mentor Programs Applications
(National Institute of Diabetes and
Digestive and Kidney Diseases)
AGENCY:

National Institutes of Health,

HHS.
ACTION:

Notice.

In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
SUMMARY:

Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Ms. Winnie
Martinez, Project Officer, 6707
Democracy Blvd., 9th Floor, Bethesda,
MD, 20892 or call non-toll-free number
(301) 435–2988 or email your request,
including your address to:
Winnie.Martinez@nih.gov.
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on March 13, 2023, page
15423–15424 (88 FR 15423) and
allowed 60 days for public comment. No
public comments were received. The
purpose of this notice is to allow an
ADDRESSES:

E:\FR\FM\06JNN1.SGM

06JNN1

37078

Federal Register / Vol. 88, No. 108 / Tuesday, June 6, 2023 / Notices

additional 30 days for public comment.
The National Institute of Diabetes and
Digestive and Kidney Diseases (NIDDK),
National Institutes of Health, may not
conduct or sponsor, and the respondent
is not required to respond to an
information collection that has been
extended, revised, or implemented on or
after October 1, 1995, unless it displays
a currently valid OMB control number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection Title: Office of
Minority Health Research Coordination
Training and Mentor Programs
Applications in use with OMB Control
Number 0925–0748, exp., date 8/31/
2026 REVISION, National Institute of
Diabetes and Digestive and Kidney

Research Training Program (DSRTP) for
Undergraduate Students, Network of
Minority Health Research Investigators
(NMRI), the NIH/National Medical
Association (NMA) Academic Career
Fellow Travel Awards, and the NIH/
National Hispanic Medical Association
(NHMA) Academic Career Fellow
Travel Awards. Identification of
participants to matriculate into the
program and initiatives comes from
applications and related forms hosted
through the NIDDK website. The
proposed information collection activity
is necessary in order to determine the
eligibility and quality of potential
awardees for traineeship in these
programs and to evaluate the effectives
of the OMHRC programs in achieving
their missions and goals.
OMB approval is requested for three
(3) years. There are no costs to
respondents other than their time. The
total estimated annualized burden hours
are 1649.

Diseases (NIDDK), National Institutes of
Health (NIH).
Need and Use of Information
Collection: In 2000, the National
Institute of Diabetes and Digestive and
Kidney Diseases of the National
Institutes of Health established the
Office of Minority Health Research
Coordination to address the burden of
diseases and disorders that
disproportionately impact the health of
minority populations. One of the major
goals of the office is to build and sustain
a pipeline of researchers from
underrepresented populations in the
biomedical, behavioral, clinical, and
social sciences, with a focus on NIDDK
mission areas. The office accomplishes
this goal by administering a variety of
programs and initiatives to recruit high
school through post-doctoral
educational level individuals into
OMHRC research training and mentor
programs: The Short-Term Research
Experience Program to Unlock Potential
(STEP–UP), the Diversity Summer

ddrumheller on DSK120RN23PROD with NOTICES1

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Number of
responses per
respondent

Average
burden per
response
(in hours)

Total annual
burden hours

Form name

Type of respondent

Short-Term Research Experience
Program to Unlock Potential
(STEP–UP) Application.
STEP–UP Student Feedback Form ..
STEP–UP Participant Survey Form ..
Diversity Summer Research Training
Program (DSRTP) Feedback Form.
Network of Minority Health Research
Investigators (NMRI) Enrollment
Form.
NMRI Evaluation Form Day 1 ...........
NMRI Evaluation Form Day 2 ...........
NMRI Evaluation Form Day 3 ...........
NMRI Survey Form ...........................
NMRI Mentor-Mentee Agreement
Form.
NIH/National Medical Association
(NMA) Academic Career Fellow
Travel Awards Application.
NIH/NMA Feedback Form ................
NIH/NMA Academic Career Development Workshop Contact Information and Feedback Form.
NIH/National Hispanic Medical Association (NHMA) Academic Career
Fellow Travel Awards Application.
NIH/NHMA Feedback Form ..............

Individuals/Households ....................

600

1

1

600

Individuals/Households ....................
Private Sector ...................................
Individuals/Households ....................

175
2,200
14

1
1
1

15/60
5/60
20/60

44
183
5

Private Sector ...................................

200

1

15/60

50

Private
Private
Private
Private
Private

...................................
...................................
...................................
...................................
...................................

120
120
120
800
100

1
1
1
1
1

10/60
10/60
10/60
30/60
30/60

20
20
20
400
50

Private Sector ...................................

200

1

20/60

67

Private Sector ...................................
Private Sector ...................................

40
1,000

1
1

30/60
5/60

20
83

Private Sector ...................................

200

1

20/60

67

Private Sector ...................................

40

1

30/60

20

Total ...........................................

...........................................................

........................

5,929

........................

1,649

VerDate Sep<11>2014

19:24 Jun 05, 2023

Jkt 259001

Sector
Sector
Sector
Sector
Sector

PO 00000

Frm 00074

Fmt 4703

Sfmt 4703

E:\FR\FM\06JNN1.SGM

06JNN1

Federal Register / Vol. 88, No. 108 / Tuesday, June 6, 2023 / Notices
Dated: May 31, 2023.
Melbourne L. Bull Jr.,
NIDDK Project Clearance Liaison, Office of
Management and Policy Analysis, National
Institute of Diabetes and Digestive and Kidney
Diseases, National Institutes of Health.
[FR Doc. 2023–11912 Filed 6–5–23; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.

ddrumheller on DSK120RN23PROD with NOTICES1

Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; Conference Grants Review
Meeting.
Date: July 6, 2023.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health, 6701 Democracy Boulevard, Room
1073, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: M. Lourdes Ponce, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Center for Advancing
Translational Sciences, National Institutes of
Health, 6701 Democracy Boulevard, Room
1073, Bethesda, MD 20892, (301) 435–0810,
lourdes.ponce@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: June 1, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–12087 Filed 6–5–23; 8:45 am]
BILLING CODE 4140–01–P

VerDate Sep<11>2014

19:24 Jun 05, 2023

Jkt 259001

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; R13
Conference Grant Review.
Date: July 18, 2023.
Time: 11:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W542, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Biman Chandra Paria,
Ph.D., Scientific Review Officer, Program
Coordination and Referral Branch, Division
of Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W542, Rockville, Maryland 20850,
240–858–3814, pariab@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Diet, Lipid
Metabolism, and Cancer.
Date: July 19, 2023.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W602, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Delia Tang, M.D.,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W602, Rockville, Maryland 20850,
240–276–6456, tangd@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Program Project (P01) Review SEP–E.
Date: July 19, 2023.
Time: 12:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W126, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Mukesh Kumar, Ph.D.,
Scientific Review Officer, Research Program

PO 00000

Frm 00075

Fmt 4703

Sfmt 4703

37079

Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W126,
Rockville, Maryland 20850, 240–276–6611,
mukesh.kumar3@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; U01
Collaborative Research SEP.
Date: July 27, 2023.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W102, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Shakeel Ahmad, Ph.D.,
Branch Chief, Research Technology and
Contract Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W102, Rockville, Maryland 20850,
240–276–6442, ahmads@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: May 31, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–11973 Filed 6–5–23; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; AD
sequencing.
Date: July 10, 2023.
Time: 12:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.

E:\FR\FM\06JNN1.SGM

06JNN1